High serum interleukin-34 level is a predictor of poor prognosis in patients with non-viral hepatocellular carcinoma.
Yu NodaTakumi KawaguchiMasaaki KorenagaSachiyo YoshioSho KomukaiMasahito NakanoTakashi NiizekiHironori KogaAtsushi KawaguchiTatsuya KantoTakuji TorimuraPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2019)
Interleukin-34 was an independent factor for survival of non-viral HCC patients. Interleukin-34 might be associated with prognosis through tumor and hepatic fibrosis factors.